“Immune microenvironment in high-grade serous ovarian carcinomas: association with molecular profiles and neoadjuvant therapy outcome”, Вопр. онкол., vol. 69, no. 1, pp. 74–81, Mar. 2023, doi: 10.37469/0507-3758-2023-69-1-74-81.